PHILADELPHIA CHROMOSOME NEGATIVE ALL
Clinical trials for PHILADELPHIA CHROMOSOME NEGATIVE ALL explained in plain language.
Never miss a new study
Get alerted when new PHILADELPHIA CHROMOSOME NEGATIVE ALL trials appear
Sign up with your email to follow new studies for PHILADELPHIA CHROMOSOME NEGATIVE ALL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for tough leukemia: drug combo aims to boost remission
Disease control Recruiting nowThis study tests a new combination of drugs for people with acute lymphoblastic leukemia that has come back or not responded to treatment. The approach adds a low dose of venetoclax (a targeted drug) and itraconazole to a standard chemotherapy regimen called TACL. The goal is to …
Matched conditions: PHILADELPHIA CHROMOSOME NEGATIVE ALL
Phase: PHASE2 • Sponsor: Hospital Universitario Dr. Jose E. Gonzalez • Aim: Disease control
Last updated May 17, 2026 03:40 UTC
-
New combo therapy aims to boost remission in adult leukemia patients
Disease control Recruiting nowThis study tests whether adding CAR-T cell therapy after standard chemotherapy can help adults newly diagnosed with a type of leukemia (Ph-negative B-ALL) achieve deeper remission and live longer. About 77 participants will receive the combination treatment. The goal is to reduce…
Matched conditions: PHILADELPHIA CHROMOSOME NEGATIVE ALL
Phase: NA • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated May 13, 2026 16:01 UTC